Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.2% |
| 2 | Healthcare | 7.6% |
| 3 | Financials | 5.15% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Industrials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
PUT
Fair Isaac
FICO
$22.7B
| $1.48M | ﹤0.01% |
1,700
+1,200
| +240% | +$1.03M |
|
3777
PUT
SolarEdge
SEDG
$2.96B
| $1.48M | ﹤0.01% |
+11,400
| New | +$2.19M |
|
|
AFMD
3778
DELISTED
Affimed
AFMD
| $1.48M | ﹤0.01% |
308,836
-8,910
| -3% | -$49.1K |
|
3779
PUT
Molson Coors Class B
TAP
$7.9B
| $1.48M | ﹤0.01% |
23,200
-40,700
| -64% | -$2.65M |
|
3780
State Street Blackstone Senior Loan ETF
SRLN
$5.32B
| $1.47M | ﹤0.01% |
35,172
-42,129
| -54% | -$1.76M |
|
3781
Johnson Outdoors
JOUT
$504M
| $1.47M | ﹤0.01% |
26,943
-21,909
| -45% | -$1.24M |
|
3782
Apyx Medical
APYX
$180M
| $1.47M | ﹤0.01% |
460,209
+258,637
| +128% | +$1.21M |
|
|
AAIC
3783
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.47M | ﹤0.01% |
343,625
+293,274
| +582% | +$1.33M |
|
3784
Wave Life Sciences
WVE
$1.18B
| $1.47M | ﹤0.01% |
254,894
-506,495
| -67% | -$2.31M |
|
|
CHUY
3785
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.46M | ﹤0.01% |
41,139
-183,590
| -82% | -$7.05M |
|
|
EPIX
3786
DELISTED
ESSA Pharma
EPIX
| $1.46M | ﹤0.01% |
473,556
+4,554
| +1% | +$13.1K |
|
3787
Standex International
SXI
$3.93B
| $1.46M | ﹤0.01% |
10,032
-9,316
| -48% | -$1.39M |
|
3788
CALL
Ares Management
ARES
$32.1B
| $1.46M | ﹤0.01% |
+14,200
| New | +$1.44M |
|
|
NKLA
3789
DELISTED
Nikola Corporation Common Stock
NKLA
| $1.46M | ﹤0.01% |
31,006
+24,573
| +382% | +$1.28M |
|
3790
Harvard Bioscience
HBIO
$28.7M
| $1.46M | ﹤0.01% |
33,947
+7,382
| +28% | +$341K |
|
3791
Intercorp Financial Services
IFS
$6.57B
| $1.46M | ﹤0.01% |
64,694
+16,816
| +35% | +$403K |
|
3792
Bread Financial
BFH
$4.55B
| $1.45M | ﹤0.01% |
42,465
-109,456
| -72% | -$4.01M |
|
3793
TriMas Corp
TRS
$1.45B
| $1.45M | ﹤0.01% |
58,630
+29,292
| +100% | +$761K |
|
3794
Century Communities
CCS
$2.01B
| $1.45M | ﹤0.01% |
21,687
+14,264
| +192% | +$1.04M |
|
|
EXAI
3795
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $1.45M | ﹤0.01% |
+320,274
| New | +$2.07M |
|
3796
CALL
Prologis
PLD
$130B
| $1.45M | ﹤0.01% |
12,900
-300
| -2% | -$36.7K |
|
3797
CALL
Ironwood Pharmaceuticals
IRWD
$706M
| $1.45M | ﹤0.01% |
+150,100
| New | +$1.47M |
|
|
3798
PUT
Ironwood Pharmaceuticals
IRWD
$706M
| $1.45M | ﹤0.01% |
+150,100
| New | +$1.47M |
|
3799
Integer Holdings
ITGR
$4.24B
| $1.45M | ﹤0.01% |
18,427
-81,218
| -82% | -$6.88M |
|
3800
Phathom Pharmaceuticals
PHAT
$684M
| $1.45M | ﹤0.01% |
139,348
+111,407
| +399% | +$1.53M |
|
Similar funds
Millennium Management's Q3 2023 Portfolio in Review
As of Q3 2023, Millennium Management held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management's Q3 2023 filing shows 836 new, 2,327 increased, 2,312 reduced and 834 closed positions. Its largest new stake was Mobileye: 2,953,164 shares worth $123M. The largest sale was iShares Core S&P 500 ETF, an estimated $689M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Millennium Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Millennium Management fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Millennium Management's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Millennium Management opened 836 new positions and closed 834 in Q3 2023.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.